Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06818032 · ClinicalTrials.gov registry record · NA

Avocado and Postprandial Responses

A NA study of Healthy and Healthy Volunteers, sponsored by University of Vermont Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06818032: Recruiting NA study of Healthy and Healthy Volunteers, sponsored by University of Vermont Medical Center.

NCT06818032 is a NA study of Healthy and Healthy Volunteers that is actively recruiting participants, run by University of Vermont Medical Center. The registered enrollment target is 30 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06818032, a NA study of Healthy and Healthy Volunteers, is actively recruiting participants, sponsored by University of Vermont Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see how adding avocado to a breakfast meal affects blood sugar control and signals of hunger and fullness after eating. The investigators will test the effects of 3 breakfast meals on blood sugar control and signals of hunger and fullness after eating: 1. Whole-wheat bread and strawberry jam 2. Whole-wheat bread, strawberry jam, and avocado 3. Whole-wheat bread and strawberry jam (meal enriched with fat and fiber to mimic that of an avocado) Participants will undergo 3 test periods, each separated by a week. Each test period consists of one day with set meals that the investigators will provide (breakfast, lunch, and dinner), and then the next morning, participants will eat a breakfast meal and have blood drawn several times over 4 hours.

Primary Outcome

Blood glucose and insulin concentrations will be measured.

Conditions Studied

Healthy Healthy Volunteers Healthy Volunteer Healthy Subjects Healthy Adult Healthy Male and Female Subjects Healthy Volunteers Only Healthy Non-smokers

Interventions

  • OTHER Negative control
  • OTHER Avocado
  • OTHER Fat and fiber addition

Study Locations (1)

Vermont

  • Clinical Research Center, University of Vermont Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03
Est. Completion 2026-06
Phase NA
University of Vermont Medical Center

27 total trials

What NCT06818032 shows while recruiting

NCT06818032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower).

The record links to 8 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Negative control is the first listed.

NCT06818032 reports a single indexed study location in Vermont.

Frequently Asked Questions

What is clinical trial NCT06818032 about?

NCT06818032 is a clinical study titled "Avocado and Postprandial Responses". The purpose of this study is to see how adding avocado to a breakfast meal affects blood sugar control and signals of hunger and fullness after eating. The investigators will test the effects of 3 breakfast meals on blood sugar control and signals of hunger and fullness after eating: 1. Whole-whea...

What is the current status of trial NCT06818032?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03. Estimated completion is 2026-06.

What conditions does trial NCT06818032 study?

This clinical trial studies the following conditions: Healthy, Healthy Volunteers, Healthy Volunteer, Healthy Subjects, Healthy Adult.

What interventions are being tested in trial NCT06818032?

The interventions under investigation include: Negative control (OTHER), Avocado (OTHER), Fat and fiber addition (OTHER).

Who is sponsoring clinical trial NCT06818032?

This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06818032 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06818032's enrollment target sits among peer trials

30 678th of 1090 higher than 363 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT06818032

Source: ClinicalTrials.gov NCT06818032, the US trial registry maintained by the National Library of Medicine. NCT06818032 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.